Skip to main content
. 2023 Oct 7;39(12):2609–2619. doi: 10.1007/s10554-023-02956-1

Table 5.

CAG and OCT findings for different LDL-C levels

Overall
(n = 216)
LDL-C < 2.51 mmol/L
(n = 123)
LDL-C ≥ 2.51 mmol/L (n = 93) p value
CAG finding
Lesion length, mm 12.05 (8.80-17.15) 11.50 (8.60–16.70) 12.60 (8.85–17.85) 0.154
Multivessel disease 170 (78.7) 91 (74.0) 79 (84.9) 0.051
Reference vessel diameter, mm 3.19 ± 0.41 3.19 ± 0.41 3.19 ± 0.41 0.924
MLD, mm 1.16 ± 0.22 1.16 ± 0.21 1.15 ± 0.24 0.945
Diameter stenosis, % 63.63 ± 6.00 63.53 ± 5.73 63.76 ± 6.37 0.784
ISR location 0.922
LAD 133 (61.6) 75 (61.0) 58 (62.4)
LCX 23 (10.6) 14 (11.4) 9 (9.7)
RCA 60 (27.8) 34 (27.6) 26 (28.0)
ISR pattern 0.395
Focal 86 (39.8) 52 (42.3) 34 (36.6)
Diffuse 130 (60.2) 71 (57.7) 59 (63.4)
Previous stent type
First-generation DES 159 (73.6) 88 (71.5) 71 (76.3) 0.889
New-generation DES 46 (21.3) 29 (23.6) 17 (18.3)
Unknown 11 (5.1) 6 (4.9) 5 (5.4)
OCT finding
Quantitative analysis
MLA, mm2 1.68 ± 0.58 1.72 ± 0.57 1.62 ± 0.60 0.223
Stent area (MLA site), mm2 6.58 ± 1.62 6.70 ± 1.68 6.43 ± 1.55 0.236

Neointimal tissue area

(MLA site), mm 2

4.90 ± 1.47 4.97 ± 1.52 4.81 ± 1.40 0.408
Burden of neointimal tissue (MLA site), % 73.81 ± 8.73 73.53 ± 8.26 74.17 ± 9.36 0.594
Qualitative analysis
NA 117 (54.2) 52 (42.3) 65 (69.9) < 0.001
TCFA 42 (19.4) 17 (13.8) 25 (26.9) 0.016
Intimal rupture 40 (18.5) 16 (13.0) 24 (25.8) 0.017
Plaque erosion 60 (27.8) 27 (22.0) 33 (35.5) 0.028
Macrophage 42 (19.4) 22 (17.9) 20 (21.5) 0.506
NV 96 (44.4) 54 (43.9) 42 (45.2) 0.854
Thrombus 54 (25.0) 24 (19.8) 30 (32.3) 0.038

Data are expressed as the median (interquartile range), mean ± SD, or n (%). CAG: coronary angiography; DES: drug eluting stent; ISR: in-stent restenosis; LAD: left anterior descending artery; LCX: left circumflex artery; LDL-C: low-density lipoprotein cholesterol; MLA: minimum lumen area; MLD: minimal lumen diameter; NA: neoatherosclerosis; NV: neovascularization; OCT: optical coherence tomography; RCA: right coronary artery; TCFA: thin-cap fibroatheroma